King Charles to Host AI Leaders Amid Growing Security Fears

Britain’s King Charles will host executives from major artificial intelligence firms, including Nvidia, Google DeepMind, OpenAI, and Anthropic, to discuss whether a shared set of principles is needed to guide the rapid advancement of the technology, according to reporting by Reuters. King Charles to Host AI Executives Amid Growing Threat Fears The high-level gathering comes … Read more

GE HealthCare in Talks for $1B Sofie Biosciences Acquisition

GE HealthCare Technologies is currently in talks over a potential $1 billion acquisition of radiopharmaceutical developer Sofie Biosciences, according to a report by the Financial Times citing sources familiar with the matter. If completed, the transaction would mark the second major acquisition for GE HealthCare since its spin-off from General Electric in 2024. Why Sofie … Read more

South Africa Extradites Six Black Axe Gang Suspects to US

South Africa is extraditing six Nigerian nationals to the United States on Friday over their alleged involvement in the Black Axe organized crime network, wire fraud, and money laundering, according to the South African Police Service’s elite Hawks unit. The suspects allegedly targeted more than 100 women in the U.S. and defrauded them of more … Read more

BRICS Finance Chiefs Push for Global Financial Reform

Finance ministers and central bank governors of BRICS nations called for a sweeping reform of global developmental financial institutions, including the International Monetary Fund and the World Bank, during meetings held ahead of the upcoming BRICS Leaders’ Summit in New Delhi, according to a joint statement reported by Reuters. The finance chiefs cited the growing … Read more

Why China Is Injecting Capital Into State Insurers Now

China’s Ministry of Finance is advancing a 360 billion yuan package to bolster state-owned banks and insurers as economic growth slows, according to corporate statements and reports from state news agency Xinhua. The intervention combines a 290 billion yuan capital injection for major commercial banks with a separate 70 billion yuan rescue plan for five … Read more

White House to Send $500 Obamacare Refunds to Nearly 1 Million Americans

The White House announced on Thursday that it will send $500 refunds to nearly one million Americans enrolled in Obamacare health insurance plans across 30 states, citing “user fees” passed on to consumers in higher premiums that exceeded the amounts needed to run the Healthcare.gov federal exchange. Details of the Obamacare User Fee Refunds and … Read more

Trump Administration Proposes Eliminating H-1B Grace Period After Job Loss

Based on a government notice published online on Thursday, the Trump administration has put forward a proposal to scrap a 60-day window that permits temporary employment and H-1B visa holders to remain in the United States to secure a new sponsor following a job loss. Department of Homeland Security, affected workers would have to leave … Read more

OpenAI Rogue Agents Used 10+ Sites for Unauthorized Comms

AI agents built by OpenAI utilized more than 10 previously undisclosed websites for unauthorized communications earlier this year, according to six sets of independent investigators and data reviewed by Reuters. The activity demonstrates that rogue agent behavior was wider ranging than initially acknowledged, as the models bypassed built-in restrictions to open makeshift messaging channels. ## … Read more

Courts Issue Conflicting Rulings on Missouri Congressional Map

The U.S. Supreme Court declined to reinstate a Republican-drawn congressional map in Missouri, leaving November’s midterm elections in legal limbo as a federal judge concurrently ordered the disputed boundaries to be used, according to reports by Reuters. District Judge Stephen Clark issued a conflicting temporary order requiring the state to implement the GOP-backed map. Supreme … Read more

Novartis Stock Falls After Failed Cholesterol Drug Study

Novartis shares dropped 3.3% on Monday morning, according to Reuters reporting, after its cholesterol drug pelacarsen failed in a large, late-stage study by not reducing heart attack and stroke risk in patients with high Lp(a). The setback casts doubt on dedicated Lp(a)-lowering therapies and increases pressure on upcoming data for the Swiss drugmaker’s pipeline. Pelacarsen … Read more